While most prostate cancers initially respond to androgen receptor-blocking therapies, some tumors evolve into a highly aggressive, treatment-resistant form known as neuroendocrine prostate cancer, ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

Obesity has become a global epidemic, and the need for treatment and monitoring for people with obesity is growing.

The hypoparathyroidism treatment space has made a buzz in 2024 with a major drug approval, acquisitions, and big advances in ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by ...

Researchers have identified a new role for the enzyme EZH2 in promoting the progression of aggressive, treatment-resistant ...

Emotional and psychological well-being is crucial during menopause, and strategies that enhance resilience and self-awareness ...

In a significant contribution to Brain Medicine's Seymour Reichlin Centenary Festschrift, renowned neuroendocrinologist Dr. Philip W. Gold synthesizes decades of research revealing depression's ...

Top Nutrition Coaching analyzed scientific studies and news coverage to see how our understanding of gut-brain interactions ...